These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2151091)

  • 1. [Androgenization in patients with polycystic ovary syndrome].
    Gasparov AS; Pshenichnikova TIa; Alieva EA; Fedorova TA; Vetr M
    Acta Univ Palacki Olomuc Fac Med; 1990; 126():241-6. PubMed ID: 2151091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiological review of hirsutism in 250 patients.
    Morán C; Tapia MC; Hernández E; Vázquez G; García-Hernández E; Bermúdez JA
    Arch Med Res; 1994; 25(3):311-4. PubMed ID: 7803980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hirsutism.
    Shah D; Patel S
    Gynecol Endocrinol; 2009 Mar; 25(3):140-8. PubMed ID: 19347703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of late-onset adrenal 3 beta-ol-hydroxysteroid dehydrogenase deficiency in patients with hirsutism and polycystic ovaries.
    Morán C; Tena G; Herrera J; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(3):315-20. PubMed ID: 7803981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroprolactinemia in women presenting with hyperandrogenic symptoms: Implications for the management of polycystic ovary syndrome.
    Escobar-Morreale HF
    Fertil Steril; 2004 Dec; 82(6):1697-9. PubMed ID: 15589886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome.
    King J
    J Midwifery Womens Health; 2006; 51(6):415-22. PubMed ID: 17081931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term health consequences of polycystic ovaries syndrome: metabolic, cardiovascular and oncological aspects].
    Gutman G; Geva E; Lessing JB; Amster R
    Harefuah; 2007 Nov; 146(11):889-93, 908. PubMed ID: 18087838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual case of oral hirsutism in a patient with polycystic ovarian syndrome.
    Femiano F; Rullo R; Serpico R; Lanza A; Festa VM; Laino G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):e13-6. PubMed ID: 19913714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased insulin sensitivity by metformin enhances intense-pulsed-light-assisted hair removal in patients with polycystic ovary syndrome.
    Rezvanian H; Adibi N; Siavash M; Kachuei A; Shojaee-Moradie F; Asilian A
    Dermatology; 2009; 218(3):231-6. PubMed ID: 19092235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spironolactone for hirsutism in polycystic ovary syndrome.
    Christy NA; Franks AS; Cross LB
    Ann Pharmacother; 2005 Sep; 39(9):1517-21. PubMed ID: 16076921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical evaluation of hirsutism.
    Somani N; Harrison S; Bergfeld WF
    Dermatol Ther; 2008; 21(5):376-91. PubMed ID: 18844715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
    Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH
    Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome after menopause: a case report.
    Pauli S; Lobo RA
    J Reprod Med; 2004 Jun; 49(6):491-4. PubMed ID: 15283061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.
    Naessén S; Carlström K; Garoff L; Glant R; Hirschberg AL
    Gynecol Endocrinol; 2006 Jul; 22(7):388-94. PubMed ID: 16864149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.
    Carmina E; Azziz R
    Fertil Steril; 2006 Jul; 86 Suppl 1():S7-8. PubMed ID: 16798288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations in the assessment and management of patients with hirsutism.
    Barth JH
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):187-92. PubMed ID: 9263703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polycystic ovary syndrome and hair unit function disturbances in dermatological practice].
    Szpringer EA; Lutnicki KR; Zych IS
    Wiad Lek; 2006; 59(11-12):848-54. PubMed ID: 17427503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The differential diagnosis of hairy virilism in polycystic ovaries from adrenal cortical hirsutism].
    Maleeva A; Milkov V; Visheva N; Kekhaĭova M
    Vutr Boles; 1990; 29(3):93-9. PubMed ID: 2178292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.